Cost-utility analysis of increasing uptake of universal seasonal quadrivalent influenza vaccine (QIV) in children aged 6 months and older in Germany

Molnar, Daniel; Anastassopoulou, Anastassia; Nautrup, Barbara Poulsen; Schmidt-Ott, Ruprecht; Eichner, Martin; Schwehm, Markus; Dos Santos, Gael; Ultsch, Bernhard; Bekkat-Berkani, Rafik; von Krempelhuber, Alfred; Van Vlaenderen, Ilse; Van Bellinghen, Laure-Anne

dc.contributor.author	Eichner, Martin
dc.date.accessioned	2022-12-06T12:36:36Z
dc.date.available	2022-12-06T12:36:36Z
dc.date.issued	2022
dc.identifier.issn	2164-5515
dc.identifier.uri	http://hdl.handle.net/10900/133737
dc.language.iso	en	de_DE
dc.publisher	Taylor & Francis Inc	de_DE
dc.relation.uri	http://dx.doi.org/10.1080/21645515.2022.2058304
dc.subject.ddc	570	de_DE
dc.subject.ddc	610	de_DE
dc.title	Cost-utility analysis of increasing uptake of universal seasonal quadrivalent influenza vaccine (QIV) in children aged 6 months and older in Germany	de_DE
dc.type	Article	de_DE
utue.quellen.id	20220728000000_01122
utue.personen.roh	Molnar, Daniel
utue.personen.roh	Anastassopoulou, Anastassia
utue.personen.roh	Nautrup, Barbara Poulsen
utue.personen.roh	Schmidt-Ott, Ruprecht
utue.personen.roh	Eichner, Martin
utue.personen.roh	Schwehm, Markus
utue.personen.roh	Dos Santos, Gael
utue.personen.roh	Ultsch, Bernhard
utue.personen.roh	Bekkat-Berkani, Rafik
utue.personen.roh	von Krempelhuber, Alfred
utue.personen.roh	Van Vlaenderen, Ilse
utue.personen.roh	Van Bellinghen, Laure-Anne
dcterms.isPartOf.ZSTitelID	Human Vaccines & Immunotherapeutics	de_DE
dcterms.isPartOf.ZS-Issue	5	de_DE
dcterms.isPartOf.ZS-Volume	18	de_DE
utue.fakultaet	Universität Tübingen (ohne Fakultätsangabe)